Compounds > venlafaxine hydrochloride
Page last updated: 2024-08-24

venlafaxine hydrochloride and Vascular Diseases

venlafaxine hydrochloride has been researched along with Vascular Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bouckaert, F; Kho, KH; Kok, RM; Sienaert, P; Spaans, HP; Stek, ML; Tunney, OC; Van Den Berg, JF; Verwijk, E1
Aizenstein, HJ; Andreescu, C; Karim, HT; Karp, JF; Lin, C; Mizuno, A; Reynolds, CF; Wei, W1

Trials

2 trial(s) available for venlafaxine hydrochloride and Vascular Diseases

ArticleYear
Vascular risk factors in older patients with depression: outcome of electroconvulsive therapy versus medication.
    International journal of geriatric psychiatry, 2018, Volume: 33, Issue:2

    Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Logistic Models; Male; Middle Aged; Nortriptyline; Risk Factors; Serotonin and Noradrenaline Reuptake Inhibitors; Treatment Outcome; Vascular Diseases; Venlafaxine Hydrochloride

2018
Trajectories in Cerebral Blood Flow Following Antidepressant Treatment in Late-Life Depression: Support for the Vascular Depression Hypothesis.
    The Journal of clinical psychiatry, 2018, 10-23, Volume: 79, Issue:6

    Topics: Antidepressive Agents, Second-Generation; Cerebrovascular Circulation; Depressive Disorder, Major; Female; Gray Matter; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Treatment Outcome; Vascular Diseases; Venlafaxine Hydrochloride

2018